Tower Research Capital (TRC)’s Aptevo Therapeutics APVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64K | Buy |
1,192
+1,029
| +631% | +$3.14K | ﹤0.01% | 4462 |
|
|
2025
Q1 | $3.78K | Buy |
163
+109
| +202% | +$2.53K | ﹤0.01% | 4353 |
|
|
2024
Q4 | $4.68K | Buy |
54
+20
| +59% | +$1.73K | ﹤0.01% | 4414 |
|
|
2024
Q3 | $4.51K | Buy |
34
+24
| +240% | +$3.19K | ﹤0.01% | 4517 |
|
|
2024
Q2 | $2.37K | Buy |
10
+8
| +400% | +$1.89K | ﹤0.01% | 5011 |
|
|
2024
Q1 | $6.21K | Buy |
+2
| New | +$6.21K | ﹤0.01% | 4410 |
|
|
2023
Q4 | – | Hold |
0
| – | -$4.45K | – | 5213 |
|
|
2023
Q3 | – | Hold |
0
| – | -$2.18K | – | 4862 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5210 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5777 |
|
|
2022
Q4 | – | Hold |
0
| – | -$9K | – | 5855 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4632 |
|
|
2021
Q4 | – | Hold |
0
| – | -$18K | – | 6112 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3801 |
|
|
2021
Q2 | – | Hold |
0
| – | -$4K | – | 5445 |
|
|
2021
Q1 | – | Hold |
0
| – | -$9K | – | 4753 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4364 |
|
|
2020
Q3 | – | Hold |
0
| – | -$20K | – | 4805 |
|
|
2020
Q2 | – | Hold |
0
| – | -$1K | – | 3669 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2722 |
|
|
2019
Q1 | – | Hold |
0
| – | -$5K | – | 3758 |
|
|
2018
Q4 | – | Hold |
0
| – | -$1K | – | 2877 |
|
|
2018
Q3 | – | Hold |
0
| – | -$14K | – | 3550 |
|
|
2018
Q2 | – | Hold |
0
| – | -$1K | – | 2615 |
|
|
2018
Q1 | – | Hold |
0
| – | -$6K | – | 3042 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 2791 |
|
|
2017
Q3 | – | Hold |
0
| – | -$5K | – | 3763 |
|
|
2017
Q2 | – | Hold |
0
| – | -$10K | – | 1964 |
|
|
2017
Q1 | – | Hold |
0
| – | -$1K | – | 1749 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 3558 |
|